ICCM stock information

Sector:

Healthcare

Description:

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

IceCure Medical Ltd website

Current Price

$1.08

RSI

26.27

Market Capitalization:

47.3M

Beta:

1.757

Volume:

69,767

Analyst Target Price:

$ None

Economiic Fair Price:

Dividend N/A

Dividend Rate N/A

Payout Ratio

Cash12.4M

Debt667000

EPS-0.398

Profit MarginN/A

Revenue Per Share TTM0.103

Return On Equity TTM-0.846

2021 Revenue

$ 4.1M

-68.49 %

2020 Revenue

$ 13.1M

128.82 %

2019 Revenue

$ 5.7M

42.18 %

2018 Revenue

$ 4M

68.49 %

2017 Revenue

$ 2.4M

-0.42 %

2016 Revenue

$ 2.4M

2021 Free Cash Flow

$ -13.1M

-3.29 %

2020 Free Cash Flow

$ -12.7M

-99.19 %

2019 Free Cash Flow

$ -6.4M

45.79 %

2018 Free Cash Flow

$ -11.8M

-28.71 %

2017 Free Cash Flow

$ -9.2M

24.56 %

2016 Free Cash Flow

$ -12.1M

2021 Pre Tax Income

$ -9.9M

34.39 %

2020 Pre Tax Income

$ -15.1M

8.77 %

2019 Pre Tax Income

$ -16.5M

-24.20 %

2018 Pre Tax Income

$ -13.3M

-33.17 %

2017 Pre Tax Income

$ -10M

20.54 %

2016 Pre Tax Income

$ -12.6M

IceCure Medical Ltd(ICCM)